http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007134105-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate | 2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007134105-A |
| titleOfInvention | 4-OXOCHINAZOLIN-3-IL-BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CYTOKINE DISEASES |
| abstract | 1. The compound of formula I! ! where m is 0, 1 or 2; ! R1 is halo, hydroxy, cyano, trifluoromethyl, trifluoromethoxy, (1-6C) alkyl, (1-6C) alkoxy, (2-6C) alkenyl, (2-6C) alkynyl, (2-6C) alkanoyl, (1 -6C) alkylthio, (1-6C) alkylsulfinyl, (1-6C) alkylsulfonyl, hydroxy- (2-6C) alkoxy, amino (2-6C) alkoxy, cyano- (2-6C) alkoxy, (1-6C ) alkylamino (2-6C) alkoxy, di - [(1-6C) alkyl] amino (2-6C) alkoxy, (1-6C) alkoxy- (2-6C) alkoxy, carbamoyl- (1-6C) alkoxy, N- (1-6C) alkylcarbamoyl- (1-6C) alkoxy, amino (1-6C) alkyl, (1-6C) alkylamino (1-6C) alkyl, di [(1-6C) alkyl] amino (1 -6C) alkyl, carbamoyl- (1-6C) alkyl, N- (1-6C) alkylcarbamoyl- (1-6C) alkyl, hydroxy- (2-6C) alkylamino, cyan o- (2-6C) alkylamino, halo- (2-6C) alkylamino, amino (2-6C) alkylamino, (1-6C) alkoxy- (2-6C) alkylamino, (1-6C) alkylamino (2 -6C) alkylamino, di - [(1-6C) alkyl] amino (2-6C) alkylamino, heteroaryl, heteroaryl- (1-6C) alkyl, heteroaryloxy, heteroaryl- (1-6C) alkoxy, heteroarylamino, heterocyclyl, heterocyclyl- (1-6C) alkyl, heterocyclyloxy, heterocyclyl- (1-6C) alkoxy and heterocyclylamino! and where any aryl, heteroaryl or heterocyclyl group in R1 may optionally carry 1 or 2 substituents selected from hydroxy, halo, (1-6C) alkyl, (2-6C) alkenyl, (2-6C) alkynyl, -6C) cycloalkyl, (3-6C) cycloalkyl- (1-6C) alkyl, (3-6C) cycloalkyl- (1-6C) alkoxy, (1-6C) alkoxy, carboxy, (1-6C) alkoxycarbonyl, ( 1-6C) alkoxycarbonyl- (1-6C) alkyl, N- (1-6C) alkylcarbamoyl, N, N-di - [(1-6C) alkyl] carbamoyl, (2-6C) alkanoyl, amino, (1- 6C) alkylamino, di - [(1-6C) alkyl] amino, halo- (1-6C) alkyl, hydroxy- (1-6C) alkyl, (1-6C) alkoxy- (1-6C) alkyl, cyano (1-6C) alkyl, carboxy- (1-6C) alkyl, amine o- (1-6C) alkyl, (1-6C) alkylamino (1-6C) alkyl and di - [(1-6C) alkyl] amino (1-6C) alkyl,! and where any of the substituents R1, as defined above, which contains a group C� |
| priorityDate | 2005-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.